Mayfield leads $23 mln financing of Mammoth Biosciences


San Francisco-based Mammoth Biosciences, which develops CRISPR-based disease detection platform, announced it has raised $23 million in Series A funding. Mayfield led the round, which included participation from NFX and 8VC. The company, which was founded in 2017 and came out of stealth mode earlier this year, previously raised seed funding from NFX.

Source: Press release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.